Abstract
The costs of acute stroke care, length of hospital stay (LOS), and outcome in patients with cardioembolic stroke or cardioembolic transient ischemic attacks (TIA) were investigated with the aim of estimating the clinical and health-economic impacts of cerebral cardioembolism. The study population consisted of 511 consecutive patients with the diagnosis of ischemic stroke (n = 379) or TIA (n = 132) treated at the Department of Neurology, Philipps University, Marburg. Cerebral cardioembolism was defined according to the criteria of the Cerebral Embolism Task Force. Clinical status was assessed by means of Barthel index (BI) and modified Rankin Scale. Costs were calculated using a bottom-up approach. All costs (in Euros) were inflated to the 2008 level. Compared to non-cardioembolic stroke (n = 278) patients, patients who had suffered cardioembolic stroke (n = 101) had more severe clinical deficits on admission (BI 46.3 ± 27.0 vs. 59.3 ± 34.1; P < 0.01), worse recovery (BI on discharge 59.2 ± 28.9 vs. 73.1 ± 33.4; P < 0.01), and increased LOS (12.6 ± 5.7 vs. 10.0 ± 7.8 days; P < 0.01). The latter also required a relatively higher daily resource utilization due to increased expenses for personnel and diagnostics. Mean costs of acute care for patients with cardioembolic stroke [€ 4890 per patient (95% confidence interval 4460–5200)] were significantly higher than those for patients with non-cardioembolic stroke [€ 3550 (95% confidence interval 3250–3850); P < 0.01]. The clinical and health-economic impact of cardiogenic cerebral embolism on stroke care is considerable. Patients with cardioembolic stroke/TIA are more severely impaired, and they require longer hospital treatment and increased resource utilization. Costs of acute care of cardioembolic stroke/TIA patients may exceed those of non-cardioembolic stroke/TIA by up to 40%.
Similar content being viewed by others
References
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41
Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Costs of disorders of the brain in Europe. Eur J Neurol 12[Suppl 1]:1–27
Asinger RW, Dyken ML, Fisher M, Hart RG, Schermann DG (1989) Cardiogenic brain embolism. The second report of the cerebral embolism task force. Arch Neurol 46:727–743
Barber JA, Thompson SG (2000) Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19:3219–3236
Bruggenjurgen B, Rossnagel K, Roll S, Andersson FL, Selim D, Müller-Nordhorn J, Nolte CH, Jungehulsing GJ, Villringer A, Willich SN (2007) The impact of atrial fibrillation on the cost of stroke: the Berlin acute stroke study. Value Health 10:137–143
Chang KC, Tseng MC, Weng HH, Lin YH, Liou CW, Tan TY (2002) Prediction of length of stay of first-ever ischemic stroke. Stroke 33:2670–2674
Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, Dromerick AW (1999) Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 30:724–728
Federal Statistical Office of Germany. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Navigation/Statistics/Preise/Verbraucherpreise/Verbraucherpreise.psml. Accessed 10 May 2008
Ferro JM (2003) Brain embolism—answers to practical questions. J Neurol 250:139–147
Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32:2559–2566
Hallevi H, Albright KC, Martin-Schild S, Barreto AD, Grotta JC, Savitz SI (2008) The complications of cardioembolic stroke: lessons from the VISTA database. Cerebrovasc Dis 26:38–40
Janzen RWC, Kugler C (1998) Stroke database for quality assurance in stroke treatment. Nervenheilkunde 17:21–25
Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1997) Acute stroke care and rehabilitation: an analysis of the direct cost and its clinical and social determinants. The Copenhagen Stroke Study. Stroke 28:1138–1141
Kalra L, Evans A, Perez I, Knapp M, Swift C, Donaldson N (2005) A randomised controlled comparison of alternative strategies in stroke care. Health Technol Assess 9(18):1–79
Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735–2740
Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Bnurs NB, Neundoerfer B, Schoeffski O, Krobot KJ (2006) Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 37:1179–1183
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. MD State Med J 14:61–65
Mamoli A, Censori B, Casto L, Sileo C, Cesana B, Camerlingo M (1999) An analysis of the costs of ischemic stroke in an Italian stroke unit. Neurology 53:112–116
Murtagh B, Smalling RW (2006) Cardioembolic stroke. Curr Atheroscler Rep 8:310–316
OECD (2008) Purchasing power parities (PPPs) for OECD countries 1980–2007. http://www.oecd.org/dataoecd/61/56/39653523.xls. Accessed 25 Feb 2008
Advisory Council for the Concerted Action in Health Care (2002) Official tariff list for medical procedures. Nomos-Verlag, Stuttgart
Patel A, Knapp M, Perez I, Evans A, Kalra L (2004) Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 35:196–203
Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO (2000) Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068
Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. Scott Med J 2:200–215
Reed SD, Blough DK, Meyer K, Jarvik JG (2001) Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology 57:305–314
Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC (2009) Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke 40: 24–29
Stroke Unit Trialists’ Collaboration (2007) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev (4):CD000197
Sulter G, Steen C, De Keyser J (1999) Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30:1538–1541
Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R, Kloth A (2007) Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 254:1323–1329
Weimar C, Luengen M, Wagner M, Kraywinkel K, Evers T, Busse O, Haberl RL, Laaser U, Lauterbach KW, Diener HC (2002) Cost of stroke care in Germany. An analysis of the stroke data bank of the German foundation stroke-aid. Akt Neurol 29:181–190
Wilterdink JL, Furie KL, Easton JD (1998) Cardiac evaluation of stroke patients. Neurology 51:23–26
Winter Y, Wolfram C, Schöffski O, Dodel RC, Back T (2008) Long-term disease-related costs 4 years after stroke or TIA in Germany. Nervenarzt 79:918–926
Wolf P, Kannel W, d’Agostino R (1998) Epidemiology of stroke. In: Ginsberg M, Bogousslavsky J (eds) Cerebrovascular disease: pathophysiology, diagnosis and management. Blackwell, Malden, pp 834–850
Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234
Wolfe CDA, Taub NA, Woodrow EJ, Burney PGJ (1991) Assessment of scales of disability and handicap for stroke patients. Stroke 22:1242–1244
Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA (2007) Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med 167:2417–2422
Yoneda Y, Uehara T, Yamasaki H, Kita Y, Tabuchi M, Mori E (2003) Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 34:718–724
Acknowledgments
This study was supported by the Wicker Foundation, Bad Wildungen, Germany. The sponsor of the study had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, and preparation, review, or approval of the manuscript. The corresponding author had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Winter, Y., Wolfram, C., Schaeg, M. et al. Evaluation of costs and outcome in cardioembolic stroke or TIA. J Neurol 256, 954–963 (2009). https://doi.org/10.1007/s00415-009-5053-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5053-2